Several studies have reported that the function of m6A methyltransferases in malignancies, as METTL3 accelerates pri-miR221/222 maturation to promote bladder cancer progression [20], ALKBH5 activates PER1 to inhibit pancreatic cancer progression [21]. Here, ALKBH5 is linked to pancreatic neoplasm.